The Case for and Against Agilent Technologies, Inc. (A)

Agilent Technologies, Inc. (A) is an interesting player in the Healthcare space, with a focus on Medical Laboratories & Research. The stock has been active on the tape, currently trading at $69.70, up from yesterday’s close by 1.99%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.

Fundamental Analysis

Agilent Technologies, Inc. (A) currently trades with a market capitalization of $21.87 Billion. That value represents a market adjusting for revenues that have been growing by 7.02 % on a quarterly year/year basis as of the company’s last quarterly report.

You can get a sense of how sustainable that is by a levered free cash flow of $713 Million over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of $0.58 on a per share basis this quarter. Perhaps, that suggests something about why 1.14% of the outstanding share supply is held by institutional investors.

Technical Analysis

No analysis is ever complete without a thorough survey of a stock’s technical behavior. Looking at the stock’s movement on the chart, Agilent Technologies, Inc. recorded a 52-week high of $75.00. It is now trading 5.3% off that level. The stock is trading $69.41 its 50-day moving average by -0.29000000000001%. The stock carved out a 52-week low down at $50.09.

In recent action, Agilent Technologies, Inc. (A) has made a move of -3.28% over the past month, which has come on Strong relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 13.35, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 1.71% with $313.71 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of A.

Previous articleHow Does McDermott International, Inc. (MDR) Stack Up Right Now?
Next articleJust the Facts on TAL Education Group (TAL)